Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27245 |
(RS)-Eflucimibe
F12511,L-0081,F-12511,L0081 |
||
Eflucimibe is an ACAT inhibitor. Eflucimibe regulates endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. In vivo, orally administered Eflucimibe displayed high potency and efficacy as an antihypercholesterolemic compound in different cholesterol-fed animals (guinea-pig, rat, rabbit). | |||
T27245L |
Eflucimibe
L0081,F-12511 |
Acyltransferase | Metabolism |
Eflucimibe (L0081) 是一种酰基辅酶A:胆固醇酰基转移酶抑制剂,可用于治疗心血管疾病和内分泌与代谢疾病,可用于研究动脉粥样硬化和高脂血症。 |